Ablation studies in colorectal cancer have found that Programmed cell death 1 ligand 1 (PD-L1) expression in target tumor tissues and programmed death 1 (PD-1) expression in specific CD8+ and CD4+T lymphocytes are increased (57). This evidence concerns the gene CD8A and neoplasm.